v3.26.1
Schedule of management’s assessment for two operating segments (Details)
6 Months Ended 12 Months Ended
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
Integer
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Segment Reporting Information [Line Items]          
Number of segments | Integer     2    
Total revenue     $ 7,646,739 $ 13,968,535 $ 7,874,886
Total cost of revenue $ 3,153,465 $ 3,640,935 6,366,621 11,430,162 6,779,892
Telemedicine and Other Services [Member]          
Segment Reporting Information [Line Items]          
Total revenue     6,800,287 12,857,688 6,898,166
Total cost of revenue     5,630,553 10,487,767 5,948,232
Sale of Medicine and Medical Devices [Member]          
Segment Reporting Information [Line Items]          
Total revenue     846,452 1,110,847 976,720
Total cost of revenue     $ 736,068 $ 942,395 $ 831,660